These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15015710)
1. Short- and long-term effects of treatment of chronic hepatitis B and delta virus by IFN. Ormeci N Fundam Clin Pharmacol; 2003 Dec; 17(6):651-8. PubMed ID: 15015710 [TBL] [Abstract][Full Text] [Related]
2. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701 [TBL] [Abstract][Full Text] [Related]
5. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B: case selection and duration of therapy. Leung N J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721 [TBL] [Abstract][Full Text] [Related]
7. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Oliveri F; Santantonio T; Bellati G; Colombatto P; Mels GC; Carriero L; Dastoli G; Pastore G; Ideo G; Bonino F; Brunetto MR Am J Gastroenterol; 1999 May; 94(5):1366-72. PubMed ID: 10235220 [TBL] [Abstract][Full Text] [Related]
8. Treatment of delta hepatitis. Gunsar F Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Castelnau C; Le Gal F; Ripault MP; Gordien E; Martinot-Peignoux M; Boyer N; Pham BN; Maylin S; Bedossa P; Dény P; Marcellin P; Gault E Hepatology; 2006 Sep; 44(3):728-35. PubMed ID: 16941695 [TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229 [TBL] [Abstract][Full Text] [Related]
11. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B]. Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077 [No Abstract] [Full Text] [Related]
12. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Gunsar F; Akarca US; Ersoz G; Kobak AC; Karasu Z; Yuce G; Ilter T; Batur Y Antivir Ther; 2005; 10(6):721-6. PubMed ID: 16218171 [TBL] [Abstract][Full Text] [Related]
13. Natural history and treatment of chronic delta hepatitis. Yurdaydın C; Idilman R; Bozkaya H; Bozdayi AM J Viral Hepat; 2010 Nov; 17(11):749-56. PubMed ID: 20723036 [TBL] [Abstract][Full Text] [Related]
14. Management of viral hepatitis B. Pramoolsinsup C J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599 [TBL] [Abstract][Full Text] [Related]
15. Current pharmacotherapy for the treatment of chronic hepatitis B. Lagget M; Rizzetto M Expert Opin Pharmacother; 2003 Oct; 4(10):1821-7. PubMed ID: 14521491 [TBL] [Abstract][Full Text] [Related]